VEGFA and neoplasm: For cancer patients, ketamine has been shown to exert antitumor effects by antagonizing NMDA receptors on cancer cells [19, 20], while simultaneously reducing vascular endothelial growth factor (VEGF) expression [21], thereby improving the tumor microenvironment to inhibit tumor recurrence and metastasis [22].